146 studies found for:    "Rothmund-Thomson Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"Rothmund-Thomson Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation Calcium Absorption in Patients With Rothmund-Thomson Syndrome
Condition: Rothmund-Thomson Syndrome
Intervention:
2 Terminated Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias
Condition: Idiopathic Interstitial Pneumonias
Intervention:
3 Recruiting Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
Condition: Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Interventions: Drug: Adempas, Riociguat (BAY63-2521);   Device: Placebo
4 Recruiting A Linkage and Association Study in Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Familial Pulmonary Fibrosis;   Idiopathic Interstitial Pneumonia;   Familial Interstitial Pneumonia
Intervention:
5 Recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
6 Unknown  Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
Conditions: Emphysema;   Alveolitis, Fibrosing;   Cystic Fibrosis;   Bronchiectasis;   Lung Diseases
Intervention: Procedure: Pulmonary rehabilitation programme
7 Completed
Has Results
Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
Conditions: Alveolitis, Fibrosing;   Fibrosis, Pulmonary;   Hypertension, Pulmonary
Intervention: Drug: sildenafil
8 Completed Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: bosentan;   Drug: Placebo
9 Completed IPF Drug Deposition Study
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Salbutamol
10 Recruiting RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Inhaled TD139;   Drug: Placebo
11 Completed
Has Results
Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II
Condition: Pulmonary Fibrosis
Interventions: Drug: placebo;   Drug: BIBF 1120
12 Recruiting Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
13 Completed
Has Results
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Bosentan
14 Completed Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Pirfenidone;   Drug: placebo
15 Recruiting Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis
Condition: Ambulatory IPF
Interventions: Drug: Rituximab;   Drug: Placebo
16 Completed
Has Results
A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Biological: PRM-151;   Other: Placebo
17 Completed
Has Results
Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Pirfenidone;   Drug: Placebo
18 Completed Safety and Tolerability Study of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: FG-3019
19 Unknown  Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.
Conditions: Idiopathic Pulmonary Fibrosis;   Interstitial Pneumonia
Intervention:
20 Terminated The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   Lung Disease;   Pulmonary Fibrosis
Intervention: Drug: Interferon gamma-1b ("Actimmune")

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years